US Stock MarketDetailed Quotes

AN2 Therapeutics (ANTX)

Watchlist
  • 4.310
  • +0.040+0.94%
Close May 13 16:00 ET
  • 4.010
  • -0.300-6.96%
Post 20:01 ET
155.23MMarket Cap-3.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AN2 Therapeutics (ANTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.55%10.55M
-30.14%38.11M
8.24%9.32M
-14.71%10.04M
-54.56%7.22M
-36.94%11.54M
-21.66%54.55M
-54.25%8.61M
-35.25%11.77M
-4.34%15.88M
Selling and administrative expenses
-1.01%3.81M
-5.16%13.34M
-24.08%2.44M
-12.74%3.04M
7.64%4.02M
5.66%3.85M
-4.73%14.07M
-17.61%3.21M
-7.12%3.48M
21.81%3.73M
-General and administrative expense
-1.01%3.81M
-5.16%13.34M
-24.08%2.44M
-12.74%3.04M
7.64%4.02M
5.66%3.85M
-4.73%14.07M
-17.61%3.21M
-7.12%3.48M
21.81%3.73M
Research and development costs
-12.31%6.74M
-38.82%24.77M
27.46%6.88M
-15.53%7M
-73.66%3.2M
-47.53%7.69M
-26.21%40.49M
-63.82%5.4M
-42.57%8.29M
-10.26%12.15M
Operating profit
8.55%-10.55M
30.14%-38.11M
-8.24%-9.32M
14.71%-10.04M
54.56%-7.22M
36.94%-11.54M
21.66%-54.55M
54.25%-8.61M
35.25%-11.77M
4.34%-15.88M
Net non-operating interest income expense
-41.10%523K
-46.32%2.93M
-43.77%605K
-45.78%687K
-47.82%754K
-47.08%888K
12.47%5.47M
1.08M
1.27M
1.45M
Non-operating interest income
-41.10%523K
-46.32%2.93M
-43.77%605K
-45.78%687K
-47.82%754K
-47.08%888K
12.47%5.47M
--1.08M
--1.27M
--1.45M
Other net income (expense)
100.04%1K
-5,293.02%-2.23M
100.31%9K
-252.27%-2.24M
81.30%1.45M
Special income (charges)
----
--0
--0
--0
----
----
---2.23M
--9K
---2.24M
----
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
----
----
--2.23M
---9K
--2.24M
----
Other non- operating income (expenses)
----
0.00%1K
----
----
----
----
-97.67%1K
--0
-13.99%1.27M
81.30%1.45M
Income before tax
5.83%-10.03M
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
Income tax
Net income
5.83%-10.03M
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
Net income continuous Operations
5.83%-10.03M
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
Minority interest income
Net income attributable to the parent company
5.83%-10.03M
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.83%-10.03M
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
Basic earnings per share
17.14%-0.29
32.56%-1.16
-16.00%-0.29
27.91%-0.31
56.25%-0.21
37.50%-0.35
37.23%-1.72
56.14%-0.25
33.85%-0.43
40.74%-0.48
Diluted earnings per share
17.14%-0.29
32.56%-1.16
-16.00%-0.29
27.91%-0.31
56.25%-0.21
37.50%-0.35
37.23%-1.72
56.14%-0.25
33.85%-0.43
40.74%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.55%10.55M-30.14%38.11M8.24%9.32M-14.71%10.04M-54.56%7.22M-36.94%11.54M-21.66%54.55M-54.25%8.61M-35.25%11.77M-4.34%15.88M
Selling and administrative expenses -1.01%3.81M-5.16%13.34M-24.08%2.44M-12.74%3.04M7.64%4.02M5.66%3.85M-4.73%14.07M-17.61%3.21M-7.12%3.48M21.81%3.73M
-General and administrative expense -1.01%3.81M-5.16%13.34M-24.08%2.44M-12.74%3.04M7.64%4.02M5.66%3.85M-4.73%14.07M-17.61%3.21M-7.12%3.48M21.81%3.73M
Research and development costs -12.31%6.74M-38.82%24.77M27.46%6.88M-15.53%7M-73.66%3.2M-47.53%7.69M-26.21%40.49M-63.82%5.4M-42.57%8.29M-10.26%12.15M
Operating profit 8.55%-10.55M30.14%-38.11M-8.24%-9.32M14.71%-10.04M54.56%-7.22M36.94%-11.54M21.66%-54.55M54.25%-8.61M35.25%-11.77M4.34%-15.88M
Net non-operating interest income expense -41.10%523K-46.32%2.93M-43.77%605K-45.78%687K-47.82%754K-47.08%888K12.47%5.47M1.08M1.27M1.45M
Non-operating interest income -41.10%523K-46.32%2.93M-43.77%605K-45.78%687K-47.82%754K-47.08%888K12.47%5.47M--1.08M--1.27M--1.45M
Other net income (expense) 100.04%1K-5,293.02%-2.23M100.31%9K-252.27%-2.24M81.30%1.45M
Special income (charges) ------0--0--0-----------2.23M--9K---2.24M----
-Less：Restructuring and merger&acquisition ------0--0--0----------2.23M---9K--2.24M----
Other non- operating income (expenses) ----0.00%1K-----------------97.67%1K--0-13.99%1.27M81.30%1.45M
Income before tax 5.83%-10.03M31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M
Income tax
Net income 5.83%-10.03M31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M
Net income continuous Operations 5.83%-10.03M31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M
Minority interest income
Net income attributable to the parent company 5.83%-10.03M31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.83%-10.03M31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M
Basic earnings per share 17.14%-0.2932.56%-1.16-16.00%-0.2927.91%-0.3156.25%-0.2137.50%-0.3537.23%-1.7256.14%-0.2533.85%-0.4340.74%-0.48
Diluted earnings per share 17.14%-0.2932.56%-1.16-16.00%-0.2927.91%-0.3156.25%-0.2137.50%-0.3537.23%-1.7256.14%-0.2533.85%-0.4340.74%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -